¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cellular antibody"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
mixed cellular cast
È¥ÇÕ¼¼Æ÷¿øÁÖ
antibody
Ç×ü
antibody absorption
Ç×üÈí¼ö
antibody capture enzyme-linked immunosorbent assay
Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤(¹ý)
antibody diversity
Ç×ü´Ù¾ç¼º
antibody excess
Ç×ü°úÀ×
antibody excess zone
Ç×ü°úÀ×±¸¿ª
antibody half-life
Ç×ü¹Ý°¨±â
antibody identification test
Ç×üȮÀΰ˻ç
antibody removal
Ç×üÁ¦°Å
antibody screening test
Ç×ü¼±º°°Ë»ç
antibody synthesis
Ç×üÇÕ¼º
antibody valence
Ç×ü°áÇÕ°¡
antibody-binding site
Ç×ü°áÇÕºÎÀ§
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
4
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
antibody synthesis
Ç×üÇÕ¼º
antibody titer
Ç×ü°¡
antibody screening test
Ç×ü¼±º°°Ë»ç
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cellular sensitivity
¼¼Æ÷¹Î°¨µµ
cellular type
¼¼Æ÷Çü
mixed cellular cast
È¥ÇÕ¼¼Æ÷¿øÁÖ
impaired cellular immunity
¼¼Æ÷¸é¿ªºÎÀü
antibody
Ç×ü
anaphylactic antibody
¾Æ³ªÇʶô½Ã½ºÇ×ü
anti-idiotype antibody
Ç×À̵ð¿ÀŸÀÔÇ×ü, Ç×°³º°Æ¯ÀÌÇüÇ×ü
antibody diversity
Ç×ü´Ù¾ç¼º
antibody excess
Ç×ü°úÀ×
antibody half-life
Ç×ü¹Ý°¨±â
antibody removal
Ç×üÁ¦°Å
antibody synthesis
Ç×üÇÕ¼º
antibody titer
Ç×ü°¡
antibody transfer
Ç×üÀÌÀÔ
antibody valence
Ç×ü°áÇÕ°¡
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
Lewis antibody
·çÀ̽ºÇ×ü
Lutheran antibody
·çÅ×¶õÇ×ü
M2 antibody
M2 Çü Ç×ü
P antibody
P Ç×ü
Scl-70 antibody
Scl-70 Ç×ü
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
acetylcholine receptor antibody assay
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
adcc(antibody dependent cell mediated cytotoxicity)
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
albumin agglutinating antibody
¾ËºÎ¹ÎÀÀÁýÇ×ü(¡ëêó¢ù÷ô÷).
anti-La antibody
Ç×LaÇ×ü
anti-RNP antibody
Ç× RNPÇ×ü
anti-Ro antibody
Ç× RoÇ×ü
anti-SM antibody
Ç×SMÇ×ü
anti-cardiolipin antibody
Ç×Ä«µð¿À¸®ÇÉÇ×ü
anti-idiotype antibody
Ç×À̵ð¿ÀŸÀÔÇ×ü, Ç×°³º°Æ¯ÀÌÇüÇ×ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cellular interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
cellular invagination
¼¼Æ÷ÇÔÀÔ
cellular islands
¼¼Æ÷¼¶
cellular layer
¼¼Æ÷ÆÇ
cellular membrane
¼¼Æ÷¼º¸·
cellular nevus
¼¼Æ÷¼º¸ð¹Ý
cellular oncogene
¼¼Æ÷¾ÏÀ¯ÀüÀÚ
cellular oncogenes
¼¼Æ÷¼º Á¾¾çÀ¯ÀüÀÚ
cellular process
¼¼Æ÷µ¹±â
cellular protooncogenes
¼¼Æ÷¼º ¿øÁ¾¾çÀ¯ÀüÀÚ
cellular radiobiology
¼¼Æ÷¹æ»ç¼±»ý¹°ÇÐ
cellular response
¼¼Æ÷¼º¹ÝÀÀ
cellular retinoid acid-bindin gprotein
¼¼Æ÷³» ·¹Æ¼³ëÀ̵å»ê°áÇմܹé(¡Ì¿ùêÓ±ÛÜ)
cellular retinol-binding protein
¼¼Æ÷³» ·¹Æ¼³î °áÇմܹé
cellular sensitivity
¼¼Æ÷°¨¼ö¼º
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½